Sarah is enrolled in a drug study for inhaled Levaquin. In fact, she was the last patient in the Phase 2 trial before it goes to FDA approval to move on to Phase 3. (We considered blowing it off since school started, but given the importance of moving the research along, agreed to go through with it.)
All the particulars are topics for a different day... Maybe the next day Sarah is hooked up to I.V. waiting for periodic blood-letting as outlined by the procedures in this trial. I just haven't had much time for my quirky, bloggy updates... But, preliminary results show a marked improvement in lung function after only a week on inhaled Levaquin. Large airway functions increased by 10%, while small airway functions increased by 18%. And, these improvements were after Sarah developed a cold.
Dan did not qualify for the study because she was sick this summer and had to be on I.V. antibiotics. However, she is snuggling up REALLY close to her sister as she does these treatments in the hopes that some of this magical elixir wafts her way.
No comments:
Post a Comment